Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States.

Saba, Ludovic; Landau, Kevin S; Liang, Hong; Fu, Chieh-Lin; Chaulagain, Chakra P

Saba, Ludovic; Landau, Kevin S; Liang, Hong; Fu, Chieh-Lin; Chaulagain, Chakra P.

Afiliação

Saba L; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL, USA.
Landau KS; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL, USA.
Liang H; Department of Clinical Research, Cleveland Clinic Florida, Weston, FL, USA.
Fu CL; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL, USA.
Chaulagain CP; Department of Hematology and Oncology, Myeloma and Amyloidosis Program, Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL, USA. CHAULAC@ccf.org.

Leukemia ; 38(2): 435-437, 2024 02.

Article em En | MEDLINE | ID: mdl-38049508

Assuntos

Leucemia Linfocítica Crônica de Células B; Leucemia Plasmocitária; Humanos; Estados Unidos/epidemiologia; Programa de SEER; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Leucemia Plasmocitária Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Leukemia Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google